Breaking News, Collaborations & Alliances

Insilico Medicine, Sanofi Sign Strategic Research Pact Valued at $1.2B

Will leverage Insilico’s Pharma.AI platform and drug discovery scientists to identify, synthesize, and advance lead compounds to development candidates.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, entered a multi-year, multi-target strategic research collaboration with Sanofi leveraging Insilico’s Pharma.AI platform to advance drug development candidates for up to six new targets.    “We look forward to working with Insilico Medicine, a demonstrated leader in AI-powered drug discovery,” said Changchun Xiao, Head of China Research at Sanofi.  “This collaboration will leverage our complementary...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters